Skip to main content

Advertisement

Log in

Nuclear-Targeting Autoantibodies Induced Nuclear PARP Cleavage Accompanied by More Pronounced Decrease of Peripheral White Blood Cells Than Ro/SSA and La/SSB Antigen-Targeting Autoantibodies

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Autoantibody production and leukocytopenia may be linked in patients with lupus erythematosus (LE). Unclear is the ability of different autoantibody species to induce apoptosis and cell loss. Laboratory routine analyses (white blood cell counts, autoantibody detection), and flow cytometry (annexin V, CD3, CD4, CD8) have been performed in 126 consecutive LE-patients. Nuclei of PBMC were investigated flow cytometrically for the presence of the 85 kDa poly-(ADP-ribose)-polymerase (PARP) fragment. Peripheral total white blood cells (WBC), lymphocytes, T-cells, CD3+ CD4+, and CD3+ CD8+ cells were significantly decreased in patients with LE (P from 1.2 × 10−14 to P < .0008). In the presence of either antinuclear (P from 1.2 × 10−14 to P < .0008) or anti-dsDNA antibodies (P from 2.9 × 10−12 to P < .007) were significantly diminished. Differences in cell numbers in LE patients with versus without anti-Ro/SSA were less pronounced: significant differences could be only obtained in lymphocytes and T-cells (P < .02). Anti-La/SSB antibodies were accompanied by significant increased leukocytes (P < .02). PARP cleavage (85 kDa) in nuclei was preferentially observed in cases with nuclear targeting autoantibodies. These results indicate that nuclear targeting autoantibodies are associated to lower peripheral blood cells counts than Ro/SSA, and La/SSB cytoplasmic targeting autoantibodies. This provides an explanation for the pathogenesis of cytopenias associated with SLE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Navratil JS, Ahearn JM: Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus. Curr Rheumatol Rep 3:191–198, 2001

    CAS  PubMed  Google Scholar 

  2. Stollar BD, Stephenson F: Apoptosis and nucleosomes. Lupus 11:787–789, 2002

    Google Scholar 

  3. Ramirez-Sandoval R, Sanchez-Rodriguez SH, Herrera-van Oostdam D, Avalos-Diaz E, Herrera-Esparza R: Antinuclear antibodies recognize cellular autoantigens driven by apoptosis. Joint Bone Spine 70:187–194, 2003

    Google Scholar 

  4. Ohlsson M, Jonsson R, Brokstad KA: Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjogren’s syndrome. Scand J Immunol 56:456–469, 2002

    Google Scholar 

  5. Böhm I: Disruption of the cytoskeleton after apoptosis induction with autoantibodies. Autoimmunity 36:183–189, 2003

    Google Scholar 

  6. Starkebaum G: Chronic neutropenia associated with autoimmune disease. Semin Hematol 39:121–127, 2002

    Google Scholar 

  7. Guma M, Krakauer R: CD4+ lymphocytopenia in systemic lupus erythematosus. Ann Intern Med 120:168–169, 1994

    Google Scholar 

  8. Yu CL, Huang MH, Tsai CY, Tsai YY, Tsai ST, Sun KH, Han SH, Yu HS: The effect of human polyclonal anti-dsDNA autoantibodies on apoptotic gene expression in cultured rat glomerular mesangial cells. Scand J Rheumatol 27:54–60, 1998

    Google Scholar 

  9. Amasaki Y, Kobayashi S, Takeda T, Ogura N, Jodo S, Nakabayashi T, Tsutsumi A, Fujisaku A, Koike T: Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): a possible mechanism for lymphopenia. Clin Exp Immunol 99:245–250, 1995

    Google Scholar 

  10. Portales-Perez D, Alarcon-Segovia D, Llorente L, Ruiz-Arguelles A, Abud-Mendoza C, Baranda L, de la Fuente H, Ternynck T, Gonzalez-Amaro R: Penetrating anti-DNA monoclonal antibodies induce activation of human peripheral blood mononuclear cells. J Autoimmun 11:563–571, 1998

    Google Scholar 

  11. Ruiz-Arguelles A, Rivadeneyra-Espinoza L, Alarcon-Segovia D: Antibody penetration into living cells: pathogenic, preventive and immuno-therapeutic implications. Curr Pharm Des 9:1881–1887, 2003

    Google Scholar 

  12. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277, 1982

    CAS  PubMed  Google Scholar 

  13. Zhan X, Hu X, Friedman S, Maciag T: Analysis of endogenous and exogenous nuclear translocation of fibroblast growth factor-1 in NIH 3T3 cells. Biochem Biophys Res Commun 188:982–991, 1992

    Google Scholar 

  14. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349:1526–1533, 2003

    Article  CAS  PubMed  Google Scholar 

  15. Cabral AR, Alarcon-Segovia D: Autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol 9:387–392, 1997

    Google Scholar 

  16. Meilof JF, Veldhoven CH, Swaak AJ, Smeenk RJ: Production of anti-Ro/SS-A and anti-La/SS-B autoantibodies is closely coordinated in systemic lupus erythematosus and independent of anti-dsDNA production. J Autoimmun 10:67–75, 1997

    Google Scholar 

  17. Franceschini F, Calzavara-Pinton P, Quinzanini M, Cavazzana I, Bettoni L, Zane C, Facchetti F, Airo P, McCauliffe DP, Cattaneo R: Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. Lupus 8:215–219, 1999

    Google Scholar 

  18. Parodi A, Drosera M, Barbieri L, Rebora A: Counterimmunoelectrophoresis, ELISA and immunoblotting detection of anti-Ro/SSA antibodies in subacute cutaneous lupus erythematosus. A comparative study. Br J Dermatol 138:114–117, 1998

    Google Scholar 

  19. Chien JW, Lin CY: Autoantibodies to dsDNA, Ro/SSA, and La/SSB in systemic lupus erythematosus. Adv Clin Chem 37:129–172, 2003

    Google Scholar 

  20. Gorson KC, Ropper AH: Positive salivary gland biopsy, Sjogren syndrome, and neuropathy: clinical implications. Muscle Nerve 28:553–560, 2003

    Google Scholar 

  21. Meyer O: Anti-SSA/Ro and anti-SSB/La antibodies. What’s new? Ann Med Interne (Paris). 153:520–529, 2002

    Google Scholar 

  22. Hsieh SC, Yu HS, Lin WW, Sun KH, Tsai CY, Huang DF, Tsai YY, Yu CL: Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus. Clin Exp Immunol 131:506–516, 2003

    Google Scholar 

  23. Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL: Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 58:309–314, 1999

    CAS  PubMed  Google Scholar 

  24. Frank MB, Itoh K, McCubbin V: Epitope mapping of the 52-kDa Ro/SSA autoantigen. Clin Exp Immunol 95:390–396, 1994

    Google Scholar 

  25. Miranda ME, Tseng CE, Rashbaum W, Ochs RL, Casiano CA, Di Donato F, Chan EK, Buyon JP: Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. J Immunol 161:5061–5069, 1998

    PubMed  Google Scholar 

  26. Hasan T, Nyberg F, Stephansson E, Puska P, Hakkinen M, Sarna S, Ros AM, Ranki A: Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings. Br J Dermatol 136:699–705, 1997

    Google Scholar 

  27. Tiefenthaler M, Bacher N, Linert H, Muhlmann O, Hofer S, Sepp N, Amberger A, Geisen F, Obermoser G, Konwalinka G: Apoptosis of CD34+ cells after incubation with sera of leukopenic patients with systemic lupus erythematosus. Lupus 2:471–478, 2003

    Google Scholar 

  28. Alarcon-Segovia D, Ruiz-Arguelles A, Fishbein E: Antibody penetration into living cells. I. Intranuclear immunoglobulin in peripheral blood mononuclear cells in mixed connective tissue disease and systemic lupus erythematosus. Clin Exp Immunol 35:364–375, 1979

    Google Scholar 

  29. Ruiz-Arguelles A, Perez-Romano B, Llorente L, Alarcon-Segovia D, Castellanos JM: Penetration of anti-DNA antibodies into immature live cells. J Autoimmun 11:547–556, 1998

    Google Scholar 

  30. Weisbart RH, Stempniak M, Harris S, Zack DJ, Ferreri K: An autoantibody is modified for use as a delivery system to target the cell nucleus: therapeutic implications. J Autoimmun 11:539–546, 1998

    Google Scholar 

  31. Reichlin M: Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins. J Autoimmun 11:557–561, 1998

    Google Scholar 

  32. Tran HB, Ohlsson M, Beroukas D, Hiscock J, Bradley J, Buyon JP, Gordon TP: Subcellular redistribution of la/SSB autoantigen during physiologic apoptosis in the fetal mouse heart and conduction system: a clue to the pathogenesis of congenital heart block. Arthritis Rheum 46:202–208, 2002

    Google Scholar 

  33. Pourmand N, Blange I, Ringertz N, Pettersson I: Intracellular localisation of the Ro 52 kDa auto-antigen in HeLa cells visualised with green fluorescent protein chimeras. Autoimmunity 28:225–233, 1998

    Google Scholar 

  34. Zhang J, Xu Z, Jin J, Zhu T, Ma S. Induction of Ro/SSA antigen expression on keratinocyte cell membrane by heat shock and phorbol 12-myristate 13-acetate as well as estradiol and ultraviolet B. J Dermatol Sci 24:92–98, 2000

    Google Scholar 

  35. Song Q, Lees-Miller SP, Kumar S, Zhang Z, Chan DW, Smith GC, Jackson SP, Alnemri ES, Litwack G, Khanna KK, Lavin MF: DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J 15:3238–3246, 1996

    Google Scholar 

  36. Böhm I, Schild H: Apoptosis: the complex scenario for a silent cell death Molecular Imaging and Biology 5:2–14, 2003

    Google Scholar 

  37. Jeoung D, Lim Y, Lee EB, Lee S, Kim HY, Lee H, Song YW: Identification of autoantibody against poly (ADP-ribose) polymerase (PARP) fragment as a serological marker in systemic lupus erythematosus. J Autoimmun 22:87–94, 2004

    Google Scholar 

  38. McConnell JR, Crockard AD, Cairns AP, Bell AL: Neutrophils from systemic lupus erythematosus patients demonstrate increased nuclear DNA damage. Clin Exp Rheumatol 20:653–660, 2002

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ingrid Böhm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Böhm, I. Nuclear-Targeting Autoantibodies Induced Nuclear PARP Cleavage Accompanied by More Pronounced Decrease of Peripheral White Blood Cells Than Ro/SSA and La/SSB Antigen-Targeting Autoantibodies. J Clin Immunol 25, 99–105 (2005). https://doi.org/10.1007/s10875-005-2815-1

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-005-2815-1

Keywords

Navigation